Tag - IDXG

Markets

AGP cuts Interpace Biosciences PT to $9.25

Alliance Global Partners lowered its price target for Interpace Biosciences (NASDAQ:IDXG) to $9.25 from a reverse split-adjusted $21, but maintained its “buy” rating, after the company posted fourth quarter...

April 24, 2020

Markets

Janney starts Interpace Biosciences at buy; fair value estimate $12

Janney Montgomery Scott launched coverage of Interpace Biosciences (NASDAQ:IDXG) with a “buy” rating and fair value estimate of $12. The stock closed at $4.81 on April 14. Analyst Paul Knight writes that Interpace has...

April 15, 2020

Tag - IDXG

AGP cuts Interpace Biosciences PT to $9.25

Janney starts Interpace Biosciences at buy; fair value estimate $12

General

More